[go: up one dir, main page]

WO2003004532A3 - Variants d'epissures de q9ul33/q9nzz4 et q9h5p3 - Google Patents

Variants d'epissures de q9ul33/q9nzz4 et q9h5p3 Download PDF

Info

Publication number
WO2003004532A3
WO2003004532A3 PCT/EP2002/007541 EP0207541W WO03004532A3 WO 2003004532 A3 WO2003004532 A3 WO 2003004532A3 EP 0207541 W EP0207541 W EP 0207541W WO 03004532 A3 WO03004532 A3 WO 03004532A3
Authority
WO
WIPO (PCT)
Prior art keywords
splice variants
q9nzz4
q9h5p3
q9ul33
ratios
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/007541
Other languages
English (en)
Other versions
WO2003004532A2 (fr
Inventor
Lydie Bougueleret
Anne Niknejad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geneprot Inc
Original Assignee
Geneprot Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprot Inc filed Critical Geneprot Inc
Publication of WO2003004532A2 publication Critical patent/WO2003004532A2/fr
Anticipated expiration legal-status Critical
Publication of WO2003004532A3 publication Critical patent/WO2003004532A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des méthodes et des compositions de mesure des rapports des variants d'épissures de Q9UL33/Q9NZZ4 ainsi que les rapports d'épissures de Q9H5P3 dans des échantillons biologiques, particulièrement dans des tissus humains. L'invention concerne par ailleurs des méthodes et des kits de surveillance des taux d'épissures de Q9UL33/Q9NZZ4 et des taux d'épissures de Q9H5P3 chez un individu.
PCT/EP2002/007541 2001-07-05 2002-07-05 Variants d'epissures de q9ul33/q9nzz4 et q9h5p3 Ceased WO2003004532A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30319701P 2001-07-05 2001-07-05
US30318701P 2001-07-05 2001-07-05
US60/303,197 2001-07-05
US60/303,187 2001-07-05

Publications (2)

Publication Number Publication Date
WO2003004532A2 WO2003004532A2 (fr) 2003-01-16
WO2003004532A3 true WO2003004532A3 (fr) 2004-02-19

Family

ID=26973316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/007541 Ceased WO2003004532A2 (fr) 2001-07-05 2002-07-05 Variants d'epissures de q9ul33/q9nzz4 et q9h5p3

Country Status (1)

Country Link
WO (1) WO2003004532A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220144908A1 (en) * 2018-08-02 2022-05-12 Novartis Ag New myokines and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791660A1 (fr) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation Nouveau marqueur diagnostique pour variations d'épissage de gènes en association avec fonctions neurologiques
WO1999055902A1 (fr) * 1998-04-29 1999-11-04 University Of South Florida Marqueurs diagnostiques de l'infertilite chez la femme

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791660A1 (fr) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation Nouveau marqueur diagnostique pour variations d'épissage de gènes en association avec fonctions neurologiques
WO1999055902A1 (fr) * 1998-04-29 1999-11-04 University Of South Florida Marqueurs diagnostiques de l'infertilite chez la femme

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE SWALL [online] 1 March 2001 (2001-03-01), KAWAKAMI, T: "Hypothetical protein FLJ23221", XP002248568, accession no. EBI Database accession no. Q9H5P3 *
DATABASE SWALL [online] 1 May 2000 (2000-05-01), ZHU, X: "Hypothetical protein", XP002248569, accession no. EBI Database accession no. Q9UL33 *
DATABASE SWALL [online] 1 October 2000 (2000-10-01), ZHANG, Q: "HSPC176 (hypothetical protein)", XP002248570, accession no. EBI Database accession no. Q9NZZ4 *

Also Published As

Publication number Publication date
WO2003004532A2 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2002249819A1 (en) Measurement testing of blood specimens
WO2002043558A3 (fr) Procede et instrument de suture
AU2001288032A1 (en) Method and kit for the transderaml determination of analyte concentration in blood
AU2003235970A1 (en) Analysis instrument, sample analysis method and analysis device using the instrument, and method of forming opening in the instrument
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002253891A1 (en) System and methods of fluorescence, reflectance and light scattering spectroscopy for measuring tissue characteristics
AU2002347576A1 (en) Device and methods for harvesting tissue samples of known geometry
AU2002326439A1 (en) Instruments and methods for examining and quantifying cataracts
AU2003221086A1 (en) Noninvasive blood component value measuring instrument and method
AU2889201A (en) Automatic water toxicity measuring apparatus
AU2002312858A1 (en) Device and method for the optical measurement of chemical and/or biological samples
EP1130401A3 (fr) Essais pour la mesure des fragments de collagène type II dans l'urine
WO2003084384A3 (fr) Diagnostic de l'infection a flavivirus
AU3460800A (en) Method of bleaching blood samples, diagnostic method and diagnostic kit using the same
AU2002233981A1 (en) Method of testing adequacy of specimen cells
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU2003234787A1 (en) Instrument and method for measuring action signal of biological sample
AU2001280959A1 (en) Analysis of biological samples for platelet activation or coagulation activationmarkers using microparticules
WO2003004532A3 (fr) Variants d'epissures de q9ul33/q9nzz4 et q9h5p3
AU2002244751A1 (en) Quantitative diagnostic analysis of hypertonia
WO2003005033A8 (fr) Peptides associes au carcinome
AU2002322515A1 (en) Compositions, methods, and kits related to treating and diagnosing hypertension
EP1260810A3 (fr) Méthode pour calibrer un analyseur d'échantillons
AU2001267699A1 (en) Testing of leather
AU8904598A (en) Methods, kits, electrodes and compositions for assessing the level of an analyteof interest in fluid samples

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP